147 related articles for article (PubMed ID: 32083440)
21. Choline supplementation alters some amino acid concentrations with no change in homocysteine in children with cystic fibrosis and pancreatic insufficiency.
Alshaikh B; Schall JI; Maqbool A; Mascarenhas M; Bennett MJ; Stallings VA
Nutr Res; 2016 May; 36(5):418-29. PubMed ID: 27101760
[TBL] [Abstract][Full Text] [Related]
22. Deficiency of vitamins E and A in cystic fibrosis is independent of pancreatic function and current enzyme and vitamin supplementation.
Lancellotti L; D'Orazio C; Mastella G; Mazzi G; Lippi U
Eur J Pediatr; 1996 Apr; 155(4):281-5. PubMed ID: 8777920
[TBL] [Abstract][Full Text] [Related]
23. Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance.
Sheikh S; Gudipaty L; De Leon DD; Hadjiliadis D; Kubrak C; Rosenfeld NK; Nyirjesy SC; Peleckis AJ; Malik S; Stefanovski D; Cuchel M; Rubenstein RC; Kelly A; Rickels MR
Diabetes; 2017 Jan; 66(1):134-144. PubMed ID: 27495225
[TBL] [Abstract][Full Text] [Related]
24. Influence of pre-diabetic and pancreatic exocrine states on pulmonary and nutritional status in adults with Cystic Fibrosis.
Potter KJ; Boudreau V; Shohoudi A; Mailhot M; Tremblay F; Lavoie A; Carricart M; Senior PA; Rabasa-Lhoret R
J Cyst Fibros; 2021 Sep; 20(5):803-809. PubMed ID: 33353861
[TBL] [Abstract][Full Text] [Related]
25. Adolescent development and energy expenditure in females with cystic fibrosis.
Stallings VA; Tomezsko JL; Schall JI; Mascarenhas MR; Stettler N; Scanlin TF; Zemel BS
Clin Nutr; 2005 Oct; 24(5):737-45. PubMed ID: 16182037
[TBL] [Abstract][Full Text] [Related]
26. Comparison of Continuous Glucose Monitoring in Cystic Fibrosis Patients With or Without Pancreatic Exocrine Insufficiency.
Rakotoarisoa L; Weiss L; Lefebvre F; Porzio M; Ravoninjatovo B; Abely M; Boucher ID; Dubois S; Troussier F; Gilles R; Prevotat A; Kessler L
Horm Metab Res; 2022 Jun; 54(6):407-412. PubMed ID: 35272389
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic Insufficiency in Cystic Fibrosis: Influence of Inflammatory Response Genes.
Marson FAL; Bertuzzo CS; de Araujo TK; Hortencio TDR; Ribeiro AF; Ribeiro JD
Pancreas; 2018 Jan; 47(1):99-109. PubMed ID: 29215541
[TBL] [Abstract][Full Text] [Related]
28. DNA marker haplotype association with pancreatic sufficiency in cystic fibrosis.
Kerem BS; Buchanan JA; Durie P; Corey ML; Levison H; Rommens JM; Buchwald M; Tsui LC
Am J Hum Genet; 1989 Jun; 44(6):827-34. PubMed ID: 2567116
[TBL] [Abstract][Full Text] [Related]
29. Serum zinc concentration in cystic fibrosis patients with CFTR I1234V mutation associated with pancreatic sufficiency.
AbdulWahab A; Abushahin A; Allangawi M; Chandra P; Abdel Rahman MO; Soliman A
Clin Respir J; 2017 May; 11(3):305-310. PubMed ID: 26096753
[TBL] [Abstract][Full Text] [Related]
30. [Pancreatic infringement exocrine and endocrine in cystic fibrosis].
Kessler L; Abély M
Arch Pediatr; 2016 Dec; 23(12S):12S21-12S32. PubMed ID: 28231890
[TBL] [Abstract][Full Text] [Related]
31. Cholesterol malabsorption in pancreatic insufficiency: effects of enzyme substitution.
Vuoristo M; Väänänen H; Miettinen TA
Gastroenterology; 1992 Feb; 102(2):647-55. PubMed ID: 1732134
[TBL] [Abstract][Full Text] [Related]
32. Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia.
Assmann G; Kannenberg F; Ramey DR; Musliner TA; Gutkin SW; Veltri EP
Curr Med Res Opin; 2008 Jan; 24(1):249-59. PubMed ID: 18053317
[TBL] [Abstract][Full Text] [Related]
33. Vitamin D supplementation for cystic fibrosis.
Ferguson JH; Chang AB
Cochrane Database Syst Rev; 2014 May; (5):CD007298. PubMed ID: 24823922
[TBL] [Abstract][Full Text] [Related]
34. Correlation of intestinal lactulose permeability with exocrine pancreatic dysfunction.
Mack DR; Flick JA; Durie PR; Rosenstein BJ; Ellis LE; Perman JA
J Pediatr; 1992 May; 120(5):696-701. PubMed ID: 1578303
[TBL] [Abstract][Full Text] [Related]
35. Plasma immunoreactive pancreatic cationic trypsinogen in cystic fibrosis: a sensitive indicator of exocrine pancreatic dysfunction.
Durie PR; Largman C; Brodrick JW; Johnson JH; Gaskin KJ; Forstner GG; Geokas MC
Pediatr Res; 1981 Oct; 15(10):1351-5. PubMed ID: 7301457
[TBL] [Abstract][Full Text] [Related]
36. Response to a single oral dose of all-rac-alpha-tocopheryl acetate in patients with cystic fibrosis and in healthy individuals.
Winklhofer-Roob BM; Tuchschmid PE; Molinari L; Shmerling DH
Am J Clin Nutr; 1996 May; 63(5):717-21. PubMed ID: 8615354
[TBL] [Abstract][Full Text] [Related]
37. [Concentration of plasma beta-carotene in cystic fibrosis children with pancreatic insufficiency].
Laskowska-Klita T; Chełchowska M
Med Wieku Rozwoj; 2002; 6(3):267-72. PubMed ID: 12637781
[TBL] [Abstract][Full Text] [Related]
38. Malabsorption blood test: Assessing fat absorption in patients with cystic fibrosis and pancreatic insufficiency.
Mascarenhas MR; Mondick J; Barrett JS; Wilson M; Stallings VA; Schall JI
J Clin Pharmacol; 2015 Aug; 55(8):854-65. PubMed ID: 25689042
[TBL] [Abstract][Full Text] [Related]
39. Influence of pancreatic status and sex on polyunsaturated fatty acid profiles in cystic fibrosis.
Coste TC; Deumer G; Reychler G; Lebecque P; Wallemacq P; Leal T
Clin Chem; 2008 Feb; 54(2):388-95. PubMed ID: 18089657
[TBL] [Abstract][Full Text] [Related]
40. Vitamin D supplementation for cystic fibrosis.
Ferguson JH; Chang AB
Cochrane Database Syst Rev; 2012 Apr; (4):CD007298. PubMed ID: 22513949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
